Tony's Diary Package — page 1025
of 1141 pages
← p.1024 p.1026 → · this page in the original PDF · package
loyed
aster
inical
atment Guidelines
to speed innovation leading
March 16:
The Phase 1 clinical trial started for the investigational vaccine, known as mRNA-1273, codeveloped by NIH and Moderna.
Press release
Blurb: NIH/Moderna COVID vaccine Phase 1 clinical trial started
Image: 3.16.20 Phase 1 Moderna
April 17:
NIH launched the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)
initiative, a public-private partnership focused on developing treatments and vaccines for
COVID-19. ACTIV streamlined the process for adding new agents into trials and rapidly deployed
existing NIH networks of more than 620 trial sites across the U.S. and internationally. The
initiative evaluated over 800 therapeutic agents and prioritized 33 for inclusion in ACTIV master
protocols. Six of these agents have shown compelling evidence of benefit in randomized clinical
trials.
Press release
Blurb: NIH launched ACTIV, a public-private partnership to develop treatments and vaccines
Image: 4.17.20 ACTIV
April 21:
After convening a panel of academic and government experts to critically review and synthesize
available data from clinical trials and other study reports, the first NIH COVID-19 Treatment
Guidelines were published to provide clinicians with guidance on how to care for patients with
COVID-19. The panel has issued more than 50 updated editions since April 2020 and the
guidelines have been visited more than 30 million times.
Press release
Blurb: NIH published the COVID-19 Treatment Guidelines
April 29:
NIH launched the Rapid Acceleration of Diagnostics (RADx) initiative to speed innovation leading
to reliable diagnostic testing.
Press release
Blurb: NIH launched RADx initiative to speed innovation in diagnostic testing
Image: 4.29.20 RADx
May 22:
Preliminary peer-reviewed data from the ACTT-1 trial indicated that the antiviral drug
remdesivir is safe and improved clinical outcomes for hospitalized adults with COVID-19.
Press release
Blurb: Antiviral drug remdesivir found safe and effective.
Image: https://www.shutterstock.com/image-photo/medication-prepared-people-affected-bycovid19-1731814354
This is our OCR of the page, with running headers and footers removed. The
Committee's PDF
is authoritative; quote from it. Machine-readable, including the uncleaned
text: /api/page/fauci_diary/1025
Records on this page
| Record | Date | Type | Pages |
|---|---|---|---|
| August 16, 2022 | 2022-08-16 | diary entry | 1023–1031 |